Vitamin D Testing
Middle East
Updated
Reviewed by Vidhi Upadhyay
Middle East Urinary Incontinence Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Gender, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$638.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $685.2 Mn | — | — |
| 2025 (base) | $734.6 Mn | +$49.3 Mn | — |
| 2026 (forecast) | $787.4 Mn | +$52.9 Mn | +7.2% |
| 2027 (forecast) | $844.1 Mn | +$56.7 Mn | +14.9% |
| 2028 (forecast) | $904.9 Mn | +$60.8 Mn | +23.2% |
| 2029 (forecast) | $970.1 Mn | +$65.2 Mn | +32.1% |
| 2030 (forecast) | $1.04 Bn | +$69.8 Mn | +41.6% |
| 2031 (forecast) | $1.11 Bn | +$74.9 Mn | +51.8% |
| 2032 (forecast) | $1.20 Bn | +$80.3 Mn | +62.7% |
| 2033 (forecast) | $1.28 Bn | +$86.0 Mn | +74.4% |
| 2034 (forecast) | $1.37 Bn | +$92.2 Mn | +87% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $734.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.37 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, gender and end user (see all) |
| Key players | Coloplast, BD (Becton, Dickinson), Medtronic, Boston Scientific Corporation, Essity (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Urinary incontinence devices manage bladder leakage with catheters, pads, slings and nerve stimulation.
Key segments of the urinary Incontinence Devices market include product (Urinary Catheters, Absorbent Products and Slings and Bulking Agents) and gender (Women and Men).
An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the urinary Incontinence Devices market.
Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the urinary Incontinence Devices market room to grow.
Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the urinary Incontinence Devices market.
The urinary Incontinence Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by SFDA (Saudi Arabia)[1] and EDE (UAE)[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[3] and mandatory health insurance (UAE)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Council of Health Insurance. Checked 14 Nov 2026.
[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how urinary Incontinence Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Middle East.
What doctors and scientists are doing in Urinary Incontinence Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Middle East
Middle East
Middle East
Middle East
Middle East
Middle East
Healthcare Services · Middle East
Digital Health · Middle East
Pharmaceuticals · Middle East
Pharmaceuticals · Middle East
Healthcare Services · Middle East
Pharmaceuticals · Middle East